Chemoinformaics analysis of delta9-tetrahydrocannabinol
Molecular Weight | 314.469 | nRot | 4 |
Heavy Atom Molecular Weight | 284.229 | nRig | 16 |
Exact Molecular Weight | 314.225 | nRing | 3 |
Solubility: LogS | -2.006 | nHRing | 1 |
Solubility: LogP | 7.228 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 56.6778 |
nHD | 1 | BPOL | 31.8322 |
QED | 0.567 |
Synth | 3.439 |
Natural Product Likeliness | 2.306 |
NR-PPAR-gamma | 0.461 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.992 |
Pgp-sub | 0.001 |
HIA | 0.005 |
CACO-2 | -4.807 |
MDCK | 0.0000141 |
BBB | 0.261 |
PPB | 0.998736 |
VDSS | 8.804 |
FU | 0.0174261 |
CYP1A2-inh | 0.231 |
CYP1A2-sub | 0.9 |
CYP2c19-inh | 0.844 |
CYP2c19-sub | 0.896 |
CYP2c9-inh | 0.482 |
CYP2c9-sub | 0.965 |
CYP2d6-inh | 0.587 |
CYP2d6-sub | 0.174 |
CYP3a4-inh | 0.456 |
CYP3a4-sub | 0.725 |
CL | 3.088 |
T12 | 0.065 |
hERG | 0.035 |
Ames | 0.023 |
ROA | 0.451 |
SkinSen | 0.101 |
Carcinogencity | 0.071 |
EI | 0.021 |
Respiratory | 0.915 |
NR-Aromatase | 0.75 |
Antiviral | No |
Prediction | 0.787081 |